GeoPolitics Pulse

The Heartbeat of World events

Collaboration to support clinical development of PSMA-targeting theranostics in Japan

by ·

Key Takeaways. Curium and PDRadiopharma are partnering to develop PSMA-targeting theranostics for prostate cancer in Japan.Read More

Related posts:

  1. GEHC to establish new theranostics center in Germany – AuntMinnie
  2. Illuccix PSMA-PET Imaging Agent Receives UK Approval in Prostate Cancer – OncLive
  3. ACCESS Consortium Exploring Clinical Trials Collaboration & Reliance, Says UK MHRA
  4. Minamino hits double as clinical Japan thrash China | Reuters
  5. GT Voice: Development of AI tech requires global governance collaboration Google Alert – Artificial General Intelligence